Literature DB >> 14718751

Efficacy of serum nitric oxide level estimation in assessing the severity of necrotizing pancreatitis.

Srinivas Reddy Mettu1, Jai Dev Wig, Madhu Khullar, Gurpreet Singh, Rajesh Gupta.   

Abstract

BACKGROUND: The role of nitric oxide in the pathophysiology of necrotizing pancreatitis is unclear.
METHODS: In a prospective study, the clinical course of 40 patients diagnosed as having acute necrotizing pancreatitis was followed using computed tomography severity score (CTSS) and serial APACHE II scoring. The serum nitric oxide levels in the form of reactive nitrogen intermediates (RNI) were estimated on admission and on day 3. Occurrence of complications, need for intervention, incidence of organ failure, and outcome were noted. The efficacy of CTSS, APACHE II scores, and RNI levels in predicting morbidity and mortality was assessed. The correlation between CTSS, APACHE II scores, and RNI levels was studied.
RESULTS: The study group showed significantly higher levels of RNI as compared with the control group (159.1 vs. 106.0 nmol/ml, p < 0.05). The RNI levels were not affected by the occurrence of local complications or distant-organ failure. The RNI levels on admission were significantly higher in the subset of patients who developed bacterial sepsis (195.5 vs. 134.7 nmol/ml, p < 0.05). The RNI levels on admission in the non-survivors were higher as compared with those of the survivors (216.0 vs. 140.1 nmol/ml, p < 0.05). There was a significant positive correlation between the RNI levels and the CTSS in these patients (p < 0.05). There was no correlation between RNI levels and APACHE II scores.
CONCLUSIONS: Acute necrotizing pancreatitis is associated with raised serum nitric oxide levels at its early stage. Patients with higher serum nitric oxide levels are at a significantly higher risk of sepsis and mortality. Copyright 2003 S. Karger AG, Basel and IAP

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718751     DOI: 10.1159/000076021

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  11 in total

1.  Cardiocirculatory pathophysiological mechanisms in severe acute pancreatitis.

Authors:  Mónica García; José Julián Calvo
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-02-06

2.  Soluble triggering receptor expressed on myeloid cells in severe acute pancreatitis: a biological marker of infected necrosis.

Authors:  Zheng Lu; Yan Liu; Yuan-hang Dong; Xian-bao Zhan; Yi-qi Du; Jun Gao; Yan-fang Gong; Zhao-shen Li
Journal:  Intensive Care Med       Date:  2011-10-27       Impact factor: 17.440

3.  Compliance with Evidence-Based Guidelines in Acute Pancreatitis: an Audit of Practices in University of Toronto Hospitals.

Authors:  J A Greenberg; J Hsu; M Bawazeer; J Marshall; J O Friedrich; A Nathens; N Coburn; H Huang; R S McLeod
Journal:  J Gastrointest Surg       Date:  2015-11-30       Impact factor: 3.452

4.  Audit of patients with severe acute pancreatitis admitted to an intensive care unit.

Authors:  Ratender Kumar Singh; Banani Poddar; Arvind Kumar Baronia; Afzal Azim; Mohan Gurjar; Sanjay Singhal; Shilpi Srivastava; Saurabh Saigal
Journal:  Indian J Gastroenterol       Date:  2012-08-30

Review 5.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

6.  The effects of resveratrol on tissue injury, oxidative damage, and pro-inflammatory cytokines in an experimental model of acute pancreatitis.

Authors:  Ahmet Gulcubuk; Damla Haktanir; Aris Cakiris; Duran Ustek; Ozlem Guzel; Muzaffer Erturk; Funda Yildirim; Ibrahim Akyazi; Hayriye Cicekci; Mehmet Hanifi Durak; Sema Sandikci-Altunatmaz; Kemal Altunatmaz
Journal:  J Physiol Biochem       Date:  2014-02-19       Impact factor: 4.158

7.  Nitric oxide pathways and evidence-based perturbations in acute pancreatitis.

Authors:  Matthew J DiMagno
Journal:  Pancreatology       Date:  2007-09-25       Impact factor: 3.996

8.  Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.

Authors:  Vikas Jain; Prashant Shukla; R Pal; Prabhat Ranjan Mishra
Journal:  Pharm Res       Date:  2014-04-17       Impact factor: 4.200

9.  Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB.

Authors:  Lei Qiu; Guojian Yin; Li Cheng; Yuting Fan; Wenqin Xiao; Ge Yu; Miao Xing; Rongrong Jia; Ruiqing Sun; Xiuying Ma; Guoyong Hu; Xingpeng Wang; Maochun Tang; Yan Zhao
Journal:  Int J Mol Med       Date:  2015-01-16       Impact factor: 4.101

Review 10.  Clinical practice guideline: management of acute pancreatitis.

Authors:  Joshua A Greenberg; Jonathan Hsu; Mohammad Bawazeer; John Marshall; Jan O Friedrich; Avery Nathens; Natalie Coburn; Gary R May; Emily Pearsall; Robin S McLeod
Journal:  Can J Surg       Date:  2016-04       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.